The New York Times
Insys Therapeutics is a company that sold a fentanyl-based painkiller called Subsys. In May 2019, a federal jury found the company’s top executives guilty of racketeering charges in a criminal prosecution case that blamed the corporate officials for contributing to the nation’s opioid epidemic. The company’s founder, John Kapoor, and four former executives, were found to have conspired to fuel sales of Subsys by not only bribing doctors to prescribe their product but also by misleading insurers about patients’ need for the drug.
According to The New York Times report, the verdict is a sign of nationwide efforts to hold pharmaceutical and drug distribution companies and their executives accountable for the prescription opioid crisis. More than 200,000 people have overdosed on such drugs in the past two decades.
You can read the complete article here.